These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2580318)

  • 1. Enzyme linked immunosorbent assay of pepsinogen I.
    Biemond I; Pals G; Giliams JP; Kreuning J; Peña AS
    Prog Clin Biol Res; 1985; 173():55-65. PubMed ID: 2580318
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of pepsinogen I in serum by radioimmunoassay.
    Axelsson CK
    Prog Clin Biol Res; 1985; 173():43-53. PubMed ID: 2580317
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A.
    Pals G; Räsänen V; Meuwissen SG; Frants RR; Kostense PJ; Eriksson AW
    Scand J Clin Lab Invest; 1987 Feb; 47(1):29-33. PubMed ID: 3554488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophoretic and immunochemical heterogeneity of human urinary pepsinogens.
    Taggart RT
    Prog Clin Biol Res; 1985; 173():15-22. PubMed ID: 3983193
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzyme-linked immunosorbent assay of serum pepsinogen I.
    Huang SC; Miki K; Hirano K; Hayashi Y; Furihata C; Shimizu A; Ichinose M; Oka H; Matsushima T; Takahashi K
    Clin Chim Acta; 1987 Jan; 162(1):85-96. PubMed ID: 3802550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative serum pepsinogen: genetics and relationship to urinary and gastric phenotypes.
    Petersen GM; Rotter JI; Samloff IM
    Prog Clin Biol Res; 1985; 173():79-90. PubMed ID: 3983198
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum pepsinogen I levels in relation to pepsinogen phenotypes.
    Pals G; Biemond I; Défize J; Westerveld BD; Pronk JC; Meuwissen SG; Eriksson AW
    Prog Clin Biol Res; 1985; 173():91-100. PubMed ID: 3983199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays.
    Leja M; Camargo MC; Polaka I; Isajevs S; Liepniece-Karele I; Janciauskas D; Rudzite D; Kikuste I; Vanags A; Kojalo I; Folkmanis V; Kirsners A; Tolmanis I; Rabkin CS
    Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28557128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyclonal antibodies for immunochemical determination of human pepsinogens.
    Majercáková P; Kucerová Z; Sajdok J
    Sb Lek; 1999; 100(2):101-8. PubMed ID: 11220159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pepsinogens A and C: purification from human gastric mucosa and determination in serum by optimized radioimmunoassays.
    Hengels KJ; Strohmeyer G
    Z Gastroenterol; 1989 Aug; 27(8):406-11. PubMed ID: 2609705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chicken and rabbit antibodies against porcine pepsinogen A.
    Kulhavá L; Miarková E; Přikryl P; Hodek P; Tichá M; Kučerová Z
    Prague Med Rep; 2015; 116(1):16-23. PubMed ID: 25923966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum.
    Samloff IM
    Gastroenterology; 1982 Jan; 82(1):26-33. PubMed ID: 7053333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunological quantitation of human group-II pepsinogens.
    Matzku S; Zöller M; Rapp W
    Digestion; 1978; 18(1-2):16-26. PubMed ID: 729943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterization of antipeptide kallikrein 4 antibodies. Use of computer modeling to design peptides specific to Kallikrein 4.
    Harvey TJ; Dong Y; Bui L; Jarrott R; Walsh T; Clements JA
    Methods Mol Med; 2003; 81():241-54. PubMed ID: 12725124
    [No Abstract]   [Full Text] [Related]  

  • 15. [Feasibility of examining patients with peptic ulcer of the duodenum in a polyclinic].
    Galkin VA; Poliatykina TS; Antonenko NI
    Ter Arkh; 1986; 58(2):48-52. PubMed ID: 3085254
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a monoclonal antibody-based competitive inhibition enzyme-linked immunosorbent assay for detection of Bacillus piliformis isolate-specific antibodies in laboratory animals.
    Boivin GP; Hook RR; Riley LK
    Lab Anim Sci; 1994 Apr; 44(2):153-8. PubMed ID: 7518016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of human pepsinogen polymorphism by combining chromatographic and electrophoretic methods.
    Majercáková P; Kucerová Z
    Sb Lek; 2001; 102(2):105-13. PubMed ID: 12092092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method for bovine pepsinogen purification. Preparation of a specific antibody.
    Gomes MA; Lima Wdos S; Pesquero JL
    J Immunoassay; 1994 May; 15(2):157-70. PubMed ID: 8040350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.